Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial
Authors
Keywords
-
Journal
npj Vaccines
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-15
DOI
10.1038/s41541-017-0043-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine
- (2016) Eun-Ju Ko et al. JOURNAL OF IMMUNOLOGY
- The avian influenza vaccine Emerflu. Why did it fail?
- (2015) Barnaby E Young et al. Expert Review of Vaccines
- Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets
- (2015) S. Pillet et al. VACCINE
- Virus-specific T cells as correlate of (cross-)protective immunity against influenza
- (2015) Arwen F. Altenburg et al. VACCINE
- Comparative structural analysis of haemagglutinin proteins from type A influenza viruses: conserved and variable features
- (2014) Irene Righetto et al. BMC BIOINFORMATICS
- Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens
- (2014) Nathalie Landry et al. CLINICAL IMMUNOLOGY
- Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
- (2014) K. G.- I. Mohn et al. JOURNAL OF INFECTIOUS DISEASES
- Cytokine Diversity in the Th1-Dominated Human Anti-Influenza Response Caused by Variable Cytokine Expression by Th1 Cells, and a Minor Population of Uncommitted IL-2+IFNγ- Thpp Cells
- (2014) Nan Deng et al. PLoS One
- Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines
- (2014) Brian J. Ward et al. VACCINE
- Memory CD4 T Cell-Mediated Immunity against Influenza A Virus: More than a Little Helpful
- (2013) K. Kai McKinstry et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- Increase in IFNγ−IL-2+ Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza
- (2013) Jason M. Weaver et al. PLoS One
- Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant
- (2013) John J. Treanor et al. VACCINE
- H5N1 vaccines in humans
- (2013) Mariana Baz et al. VIRUS RESEARCH
- Influenza vaccines: T-cell responses deserve more attention
- (2012) Michael Schotsaert et al. Expert Review of Vaccines
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
- (2012) Jessica Chichester et al. Viruses-Basel
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
- (2011) J. R. Teijaro et al. JOURNAL OF IMMUNOLOGY
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
- (2011) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Original Article: Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses
- (2010) Venkata R. S. K. Duvvuri et al. Influenza and Other Respiratory Viruses
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
- (2010) Philippe Moris et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Cytotoxic T Cells Are the Predominant Players Providing Cross-Protective Immunity Induced by -Irradiated Influenza A Viruses
- (2010) Y. Furuya et al. JOURNAL OF VIROLOGY
- The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza
- (2010) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
- Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
- (2010) Nathalie Landry et al. PLoS One
- Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination
- (2010) Ramu A. Subbramanian et al. VACCINE
- In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine
- (2010) Haifeng Song et al. VACCINE
- Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza
- (2010) Jianping Lin et al. VACCINE
- Current status and progress of prepandemic and pandemic influenza vaccine development
- (2009) Isabel Leroux-Roels et al. Expert Review of Vaccines
- The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus
- (2009) Y. Yang et al. SCIENCE
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
- (2009) Wendy Keitel et al. VACCINE
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza virus-like particles produced by transient expression inNicotiana benthamianainduce a protective immune response against a lethal viral challenge in mice
- (2008) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More